4
Changes in Ownership
ENDONOVO THERAPEUTICS, INC. Filed Acc 0001645470-19-000019
CEO bought 54,500 shares at an average $0.02 ($1,099)
From the SEC's structured data for this filing
Trades in this filing
Collier Alan Brian · CEO
Table I: Non-derivative
16 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-03-13 | Purchase : show line 1 in the form | +2,000 | $0.02 | $37 | 21,816,123 | D |
| 2019-03-13 | Purchase : show line 2 in the form | +500 | $0.02 | $10 | 21,816,623 | D |
| 2019-03-14 | Purchase : show line 3 in the form | +2,000 | $0.02 | $38 | 21,818,623 | D |
| 2019-03-14 | Purchase : show line 4 in the form | +5,000 | $0.02 | $108 | 21,823,623 | D |
| 2019-03-15 | Purchase : show line 5 in the form | +5,000 | $0.02 | $104 | 21,828,623 | D |
| 2019-03-15 | Purchase : show line 6 in the form | +5,000 | $0.02 | $105 | 21,833,623 | D |
| 2019-03-15 | Purchase : show line 7 in the form | +5,000 | $0.02 | $100 | 21,838,623 | D |
| 2019-03-15 | Purchase : show line 8 in the form | +5,000 | $0.02 | $100 | 21,843,623 | D |
| Open-market purchases · 54,500 sh · avg $0.02 · $1,099 | ||||||
Loading xslF345X03/primary_doc.xml…